{"meta":{"query_hash":"0d45cd506541","filters":{"venue":"Pharmaceutica Analytica Acta"},"cohort_total":2,"direct_labels_cover":0,"predictions_cover":2,"exported":2,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/0d45cd506541","api":"https://metacan.xera.ac/api/v1/cohort?venue=Pharmaceutica+Analytica+Acta"},"results":[{"id":"W2323142883","doi":"10.4172/2153-2435.1000313","title":"Assessment of the Health-Related Quality of Life Impact of EUFLEXXA (1% Sodium Hyaluronate) Using Short Form 36 (SF-36) Data Collected in aRandomized Clinical Trial Evaluating Treatment of Osteoarthritis Knee Pain","year":2014,"lang":"en","type":"article","venue":"Pharmaceutica Analytica Acta","topic":"Osteoarthritis Treatment and Mechanisms","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Osteoarthritis; Sodium hyaluronate; Clinical trial; Medicine; Quality of life (healthcare); Physical therapy; Alternative medicine; Internal medicine; Surgery; Pathology; Nursing","score_opus":0.30502169081634756,"score_gpt":0.5204612945682205,"score_spread":0.215439603751873,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2323142883","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99432087,0.0019280429,0.0005928853,0.00009023904,0.00002147246,0.00061437144,0.0016232389,0.000009046431,0.0007998816],"genre_scores_gemma":[0.99564457,0.00047609603,0.00094418356,0.000055982837,0.000026947966,0.00066578883,0.0018818796,0.000002072162,0.0003024975],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99548316,0.00286338,0.00045634768,0.0002468418,0.00075422815,0.0001961072],"domain_scores_gemma":[0.9963611,0.001152803,0.0016128183,0.00014869224,0.0004001847,0.00032436333],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007244431,0.00069847197,0.0009982579,0.00090097234,0.00023098348,0.0005875214,0.000351829,0.00042676344,0.0019989137],"category_scores_gemma":[0.0060807434,0.00013682208,0.0015645548,0.0008733739,0.0004454878,0.000490461,0.0006624313,0.00068160164,0.00017486051],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.11741303,0.0062960917,0.76977783,0.001672069,0.00786751,0.000111029425,0.00048373692,0.0036644395,0.004387505,0.0002995357,0.0012015991,0.08682564],"study_design_scores_gemma":[0.009375216,0.05354084,0.92740506,0.00011972749,0.0018869785,0.00017520963,0.00015361648,0.0029156192,0.0023713019,0.00018826152,0.001810047,0.00005818625],"about_ca_topic_score_codex":0.0007725647,"about_ca_topic_score_gemma":0.0012893118,"teacher_disagreement_score":0.007244431,"about_ca_system_score_codex":0.00047271966,"about_ca_system_score_gemma":0.00053010666,"threshold_uncertainty_score":0.038312733},"labels":[],"label_agreement":null},{"id":"W2534391137","doi":"","title":"Nanotechnology for improving response to cancer chemo and immunotherapy","year":2015,"lang":"en","type":"article","venue":"Pharmaceutica Analytica Acta","topic":"Nanoplatforms for cancer theranostics","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta","funders":"","keywords":"Cancer; Medicine; Immunotherapy; Chemotherapy; Cancer immunotherapy; Drug delivery; Tumor microenvironment; Immune system; Disease; Cancer cell; Immunology; Internal medicine; Nanotechnology","score_opus":0.04039780042276124,"score_gpt":0.32430865859535946,"score_spread":0.2839108581725982,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2534391137","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.16356178,0.40694937,0.2958269,0.011847408,0.0039030972,0.00080772355,0.00083571835,0.0022867292,0.1139812],"genre_scores_gemma":[0.67943853,0.14756675,0.12971956,0.0053131776,0.0011784922,0.00072962407,0.0005654532,0.0002463603,0.035242073],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997297,0.000050528863,0.000015989051,0.000054599775,0.000107215536,0.00004189585],"domain_scores_gemma":[0.999856,0.00005113411,0.000032102034,0.000012671096,0.00003242801,0.000015728867],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038614916,0.00033922074,0.00036375478,0.0005163749,0.00025463494,0.000626087,0.00034345925,0.00092236866,0.0032339767],"category_scores_gemma":[0.00048162884,0.00018694879,0.0003451158,0.00026425396,0.00037507567,0.000756324,0.0005802297,0.000944435,0.0012428251],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008054476,0.00009832814,0.00036513727,0.000981743,0.000025115856,0.0001604937,0.00008191762,0.0015706733,0.8661457,0.015006132,0.0045714215,0.110912815],"study_design_scores_gemma":[0.000045095167,0.0011467515,0.0017153682,0.00027030497,0.000075134565,0.001202762,0.00011204738,0.009624005,0.6392737,0.009573347,0.33691242,0.000049006674],"about_ca_topic_score_codex":0.00031975398,"about_ca_topic_score_gemma":0.0005325868,"teacher_disagreement_score":0.0032339767,"about_ca_system_score_codex":0.0005068646,"about_ca_system_score_gemma":0.00043902086,"threshold_uncertainty_score":0.01081872},"labels":[],"label_agreement":null}]}